Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    8196732 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:
2 Terminated Myfortic Versus Azathioprine in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: switch to Myfortic;   Drug: continuation of azathioprine

Indicates status has not been verified in more than two years